Inactive Instrument

Zeltia SA Stock

Stocks

ES0184940817

Biotechnology & Medical Research

End-of-day quote BME
- ^EUR	-

11/11/15	Alibaba's Singles' Day sales surge 60 percent to $14.3 billion	RE
04/11/15	Alibaba : China consumers to spend more in November 11 'Singles Day' shopping spree - Nielsen	RE

Latest news : Zeltia SA

11/11/15	Alibaba's Singles' Day sales surge 60 percent to $14.3 billion	RE
04/11/15	Alibaba : China consumers to spend more in November 11 'Singles Day' shopping spree - Nielsen	RE
17/12/14	Hyundai Heavy : Thomson Reuters/INSEAD Asia Business Sentiment Survey fourth quarter 2014 - PDF	RE
17/12/14	Hyundai Heavy : Thomson Reuters/INSEAD fourth quarter Asian Business Sentiment Survey - by economy	RE
17/12/14	Hyundai Heavy : Thomson Reuters/INSEAD fourth quarter Asian Business Sentiment Survey - by sector	RE
03/11/14	Inditex : Daughter of Zara founder declares 5 percent Inditex stake	RE
05/02/14	Bell Aliant Inc : Canada tightens rules on cellphone towers	RE
17/12/13	Vodafone Group plc : Insight - The Luxembourg tax break that helps firms profit from loss	RE
18/10/13	Google Inc : Google shares break $1,000 barrier as mobile pays off	RE
18/10/13	Berkshire Hathaway Inc. : Google shares break $1,000 barrier as mobile pays off	RE
18/10/13	Canadian Solar Inc. : China's pioneers to drive recovery in solar equipment demand	RE
16/10/13	Verizon Communications Inc. : Telecom tycoon says Ottawa's policy imperils Wind, foreign investment	RE

Press Releases: Zeltia SA

26/10/15	Zeltia : PharmaMar to Present New Studies for YONDELIS® and PM1183 in Ovarian Cancer during ESGO 2015	PU
23/10/15	Zeltia : U.S. FDA Approves YONDELIS® (trabectedin) for Soft Tissue Sarcoma (Liposarcoma or Leiomyosarcoma)	PU
21/10/15	Zeltia : Grupo Zeltia reports 126.8 million euro in net sales (+8.5%) in the first nine months of 2015	PU
21/09/15	Zeltia : Enrollment of first patient in a Phase II trabectedin study in brain tumor type called meningioma	PU
17/09/15	Zeltia : PharmaMar initiates a phase II “Basket” trial for PM1183 in selected advanced solid tumors	PU

More press releases

News in other languages: Zeltia SA

15/12/15	DJ Industrial : Wall Street termine dans le vert une séance volatile
17/11/15	China CITIC Bank : Les valeurs à suivre sur les marchés américains
28/07/15	DJ Industrial : Wall Street finit en hausse, les craintes sur la Chine refluent
27/07/15	DJ Industrial : Wall Street plombée par la chute des Bourses chinoises
26/05/15	Les valeurs à suivre sur les marchés américains

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	LONZA GROUP AG	+1.09%	+5.26%	+4.44%	+26.03%	51.61B
	REVOLUTION MEDICINES, INC.	-1.07%	+2.82%	+474.18%	+601.24%	44.89B
	IQVIA HOLDINGS INC.	+1.47%	+9.79%	+40.15%	+21.21%	42.77B
	BEONE MEDICINES AG	+1.44%	+7.77%	+19.27%	+90.94%	42.58B
	CELLTRION, INC.	-0.93%	-4.33%	+17.87%	+51.96%	31.82B
	MEDPACE HOLDINGS, INC.	+1.32%	+7.30%	+36.93%	+152.36%	17.33B
	ASCENDIS PHARMA A/S	-0.60%	+1.93%	-	-	16.63B
	EUROFINS SCIENTIFIC SE	+0.03%	+3.41%	+7.12%	+35.49%	14.76B
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.28%	+5.41%	+91.01%	+46.93%	14.09B
	Average	+0.45%	+4.43%	+86.37%	+128.27%	30.72B
	Weighted average by Cap.	+0.49%	+4.72%	+102.57%	+148.52%

See all sector performances

Company Profile

Employees

-

Sector

Biotechnology & Medical Research

More about the company

As early as today, start finding the best investment opportunities!